Rapport Therapeutics grants 15,200 stock options
Rapport Therapeutics director Ramiro Sanchez received a grant of stock options covering 15,200 shares of Common Stock of Rapport Therapeutics, Inc. The options have an exercise price of $35.21 per share and expire on June 10, 2036.
Rhea-AI Filing Summary
Rapport Therapeutics director Ramiro Sanchez received a grant of stock options covering 15,200 shares of Common Stock of Rapport Therapeutics, Inc. The options have an exercise price of $35.21 per share and expire on June 10, 2036.
The 15,200 option shares vest on the earlier of June 10, 2027 or the date of the next Annual Meeting of Stockholders, subject to Sanchez’s continued service. Following this award, he holds 15,200 derivative securities directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 15,200 shares
Grant/Award
1 txn
Insider
Sanchez Ramiro
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 15,200 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 15,200 contracts (Direct)
Footnotes (1)
- F1. The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.
Key Figures
Option grant size: 15,200 options
Exercise price: $35.21 per share
Expiration date: June 10, 2036
+3 more
6 metrics
Option grant size
15,200 options
Stock Option (Right to Buy) granted to director
Exercise price
$35.21 per share
Conversion or exercise price of stock option
Expiration date
June 10, 2036
Option expiration for 15,200-share grant
Underlying shares
15,200 shares
Common Stock underlying the options
Post-grant holdings
15,200 derivative securities
Total options held following transaction
Vesting date trigger
June 10, 2027
Latest vesting date, or earlier next Annual Meeting
Key Terms
Stock Option (Right to Buy), Common Stock, Annual Meeting of Stockholders, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Annual Meeting of Stockholders financial
"the date of the next Annual Meeting of Stockholders of the Issuer"
vesting financial
"The shares underlying this option shall vest upon the earlier of"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
derivative securities financial
"derivativeTransactionCount: 1, derivative-type records reported"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Rapport Therapeutics (RAPP) report for Ramiro Sanchez?
Rapport Therapeutics reported that director Ramiro Sanchez received a grant of stock options for 15,200 shares of Common Stock. These options are a compensation-related award, not an open-market purchase or sale, and give him the right to buy shares at a fixed exercise price.
What are the key terms of Ramiro Sanchez’s stock option grant at Rapport Therapeutics (RAPP)?
The grant covers 15,200 shares of Common Stock with an exercise price of $35.21 per share and an expiration date of June 10, 2036. It is classified as a derivative security (stock option) rather than current share ownership, reflecting long-term equity-based compensation.
When do Ramiro Sanchez’s Rapport Therapeutics (RAPP) options vest?
The 15,200 option shares vest on the earlier of June 10, 2027 or the date of the next Annual Meeting of Stockholders. Vesting is conditioned on Sanchez’s continued service with the company through the applicable vesting date under the award’s terms.
Is Ramiro Sanchez’s Form 4 transaction a buy or sell of Rapport Therapeutics (RAPP) stock?
The Form 4 reports an acquisition of derivative securities through a grant, not an open-market buy or sell. Sanchez received 15,200 stock options as a grant, giving him the right to purchase shares in the future at $35.21 per share if he chooses.
How many Rapport Therapeutics (RAPP) securities does Ramiro Sanchez hold after this option grant?
After the reported transaction, Sanchez holds 15,200 derivative securities directly, corresponding to options on 15,200 shares of Common Stock. The filing does not show additional derivative positions, and this total reflects his holdings following the reported grant on the transaction date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
